Clinical trials
Hormones clinical trials
Below are recruiting hormones clinical trials, each written for real people, not researchers. We’re tracking 413 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07742488Recruiting
Statins and hormone therapy for cholesterol in menopause
This study looks at whether taking statins (cholesterol-lowering medicine) along with hormone replacement therapy (HRT) affects blood clotting in women going through menopause who have high cholesterol. It may help doctors understand how these medicines work together.
Pisa, ItalyAges 45–55 - NCT06910293Recruiting
Brain Activity During Menstrual Cycle vs. Fertility Treatment
This study looks at how natural menstrual cycles and ovarian stimulation (which mimics some fertility treatments) affect brain activity and hormone levels. Researchers want to understand normal brain changes during the cycle to help improve fertility treatments.
Abu Dhabi, Abu Dhabi EmirateAges 25–35 - NCT05878314Recruiting
Testing how hormones and tumor markers guide breast cancer treatment
This study looks at how planned hormone (endocrine) treatment, the menstrual cycle, and lab markers from the tumor may help doctors choose the best treatment for early-stage, hormone-receptor–positive, HER2-negative breast cancer. It may help personalize decisions, including what to do before surgery.
TübingenAges 18 years+ - NCT06734533Recruiting
Anlotinib combo for HR+ breast cancer that has spread
This trial tests a combination treatment including anlotinib for women with hormone receptor-positive breast cancer that has spread to other parts of the body and has stopped responding to standard therapies. It is for those who have already tried a CDK4/6 inhibitor and endocrine therapy.
Changsha, HunanAges 18–75 - NCT06733415Enrolling by invitation
Hormone therapy and energy changes in transgender people
This study looks at how starting gender-affirming hormone therapy changes the way your body uses energy. It might help explain weight and metabolism changes some people notice during treatment.
Tel AvivAges 17 years+ - NCT06679491Recruiting
How your menstrual cycle affects strength training
This study looks at how resistance training timed to your menstrual cycle affects muscle performance in women who have a natural cycle or take the pill.
Le Tampon, FranceAges 18 years+ - NCT07380854Recruiting
Thyroid Hormone After Heart Bypass for Mild Underactive Thyroid
This study looks at whether giving thyroid hormone replacement to people with mild underactive thyroid (subclinical hypothyroidism) after heart bypass surgery improves their recovery. It is for adults who are scheduled for bypass surgery and have not recently used thyroid or anti-thyroid medications.
Seongnam-siAges 19–90 - NCT07310485Enrolling by invitation
Phytoestrogens for premenstrual syndrome in women nearing menopause
This trial tests whether plant-based compounds (phytoestrogens) can help reduce premenstrual syndrome symptoms in women aged 40–55. It also looks at how these supplements affect gene activity.
Amman, Amman GovernorateAges 40–55 - NCT06334120Recruiting
Darolutamide safety study for men with prostate cancer in Korea
This study tracks the safety of the drug darolutamide in Korean men with a type of prostate cancer that has not spread (non-metastatic) or has spread (metastatic) and is still responding to hormone therapy. It aims to see how well patients tolerate the drug in real-world settings.
Multiple LocationsAges 19 years+ - NCT07309562RecruitingPhase 3
Growth hormone trial for short children born small
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
BeijingAges 2–11 - NCT07323329RecruitingPhase 2/Phase 3
Growth Hormone and DHEA for IVF in Women with Low Ovarian Reserve
This trial tests whether adding growth hormone and DHEA to your IVF medications can help women with low ovarian reserve get more eggs and improve pregnancy chances. It may be an option if you are over 40, have had few eggs before, or have low egg count markers.
Banī Suwayf, Beni Suweif GovernorateAges 18–35 - NCT04365179RecruitingPhase 1
NEROFE for advanced MDS or AML after other treatments
This early-phase trial tests NEROFE, a hormone-peptide medicine, in adults with advanced myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that has come back or did not respond. It aims to see if NEROFE is safe and can help patients whose disease is unlikely to benefit from standard remaining options.
Miami, FloridaAges 18 years+ - NCT07337772Recruiting
Comparing corticosteroid doses in knee replacement pain relief injection
This study compares different doses of a corticosteroid (an anti-inflammatory medicine) injected into the knee during total knee replacement surgery. The goal is to see which dose provides the best pain relief after surgery. It is for people having their first knee replacement due to osteoarthritis.
Fuzhou, FujianAges 18–100 - NCT07672717RecruitingPhase 1
Cabotegravir and hormone interaction study for HIV prevention
This study tests how a long-acting injectable HIV prevention drug (cabotegravir) works in people who also use hormone therapy (like birth control or gender-affirming hormones). The goal is to see if the hormones affect how well the drug prevents HIV. If you are HIV-negative, use hormones, and meet other health criteria, you may be able to join.
Baltimore, MarylandAges 19 years+ - NCT07396324RecruitingPhase 2
A new drug before surgery for HR+ HER2- breast cancer
This trial tests whether the drug QL1706, given before surgery, can help treat hormone receptor positive and HER2-negative breast cancer. It is for people who have not yet had cancer spread to other parts of the body.
ShanghaiAges 18 years+ - NCT07620067Recruiting
GnRH Hormone for IVF Embryo Support
This study tests whether a hormone called GnRH can improve success rates during IVF (in vitro fertilization) by supporting the embryo after transfer. If you're having IVF for the first to third time and your doctor is considering different support methods, this trial may explore options for you.
JerusalemAges 18–45 - NCT07531693Recruiting
Improving Outcomes in Early Hormone-Positive Breast Cancer
This study follows women taking abemaciclib (a targeted cancer drug) for early-stage hormone-receptor-positive breast cancer to understand how the treatment affects their quality of life and health outcomes. The goal is to improve care for people in this situation.
Erlangen, BavariaAges 18 years+ - NCT07481578Recruiting
Exercise and gut health study for active men
This study looks at how your training load affects your gut bacteria and how that relates to exercise performance and muscle health. It may help understand overreaching in healthy men.
Leuven, Vlaams BrabantAges 18–45 - NCT07258576Recruiting
Birth control vs. natural cycle: muscle response to exercise
This study compares how muscle protein responds to resistance exercise in women who use birth control pills versus those with natural menstrual cycles. Participants will do exercise sessions and have muscle samples taken to see how their bodies build protein.
Toronto, OntarioAges 18–40 - NCT07225660Recruiting
Timing of hormone shots after stopping birth control in IVF
This trial compares starting fertility hormones right after stopping birth control pills versus waiting a few days. It aims to find out which timing leads to better egg retrieval outcomes.
Orange, ConnecticutAges 18–40 - NCT06982521RecruitingPhase 3
Comparing two drug combinations for advanced breast cancer
This trial tests two different combinations of medicines for people with a certain type of advanced breast cancer (HR-positive, HER2-negative) that has a specific gene change called PIK3CA. The goal is to see which combination is better at slowing down the cancer.
Gilbert, ArizonaAges 18 years+ - NCT07747909Recruiting
Orlistat for metabolic and hormonal health in PCOS
This study tests whether the weight-loss drug orlistat can improve blood sugar, hormones, and other metabolic measures in women with polycystic ovary syndrome (PCOS). If you have PCOS and are overweight, this treatment might help with symptoms like irregular periods and excess hair growth.
Abbottābād, Khyber PakhtunkhwaAges 18–45 - NCT04794075Recruiting
Nursing and education support for women on hormone breast therapy
This trial tests a structured nursing and education program to support people with non-metastatic breast cancer who take hormone-blocking treatment. It may help you manage side effects and stay supported during follow-up, using online questionnaires and scheduled sessions.
Bourg-en-BresseAges 18–75 - NCT06931340RecruitingPhase 3
Adding chemo to hormone therapy for advanced prostate cancer
This trial is for men with metastatic prostate cancer that has already spread beyond the pelvis. It tests whether adding a chemotherapy drug (docetaxel) to the usual hormone therapy plus apalutamide can help control the cancer better than hormone therapy alone.
Tucson, ArizonaAges 18 years+
Hear when a new Hormones trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hormones?
- Yes. Clin2 currently lists 413 recruiting hormones studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hormones trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hormones trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.